What is Spiber?
Headquartered in Yamagata, Japan, Spiber Inc. operates at the intersection of synthetic biology, polymer science, and material innovation. The company is renowned for its development of novel Brewed Protein materials, which are engineered through advanced fermentation processes. These sustainable and high-performance materials are designed to offer alternatives to traditional petroleum-based polymers and animal-derived proteins, targeting applications across various industries including textiles, automotive, and healthcare. Spiber's commitment to bio-manufacturing represents a significant advancement in creating eco-friendly and functional materials.
How much funding has Spiber raised?
Spiber has raised a total of $130M across 2 funding rounds:
Other Financing Round
$65M
Other Financing Round
$65M
Other Financing Round (2024): $65M, investors not publicly disclosed
Other Financing Round (2024): $65M, investors not publicly disclosed
What's next for Spiber?
With the infusion of major enterprise-level funding and a recent strategic investment, Spiber is poised to accelerate its commercialization efforts. The company is expected to leverage this capital to enhance its production capacity, further its research and development in material science, and forge new strategic partnerships. This backing signals strong confidence in Spiber's technology and its potential to disrupt conventional material markets with sustainable, bio-based solutions. The focus will likely be on scaling manufacturing to meet growing demand and solidifying its position as a leader in the synthetic biology materials space.
See full Spiber company page
